News

The latest buzzword among Brussels technocrats is “lead markets”. And it’s going to be put into action, on an experimental basis, in 2007.

European pharma and biotech companies are behind the US. But in one shining area, Europe has outpaced the US in creating a new sector: biosimilars.

YouTube, MySpace – those are some of the hottest properties on the Internet these days. They may also be the working definition of demand-side innovation,